TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

Frank Martiniuk(Psychogenics (United States)), William R. Levis(Bellevue Hospital Center), Kam-Meng Tchou-Wong(New York University), John F. Thompson(Melanoma Institute Australia), Diona L. Damian(The University of Sydney), Richard A. Scolyer(The University of Sydney)
PubMed
November 1, 2010
Cited by 23


Related Papers